VKTX – Viking Therapeutics, Inc.
Float Short %
26.31
Margin Of Safety %
Put/Call OI Ratio
0.29
EPS Next Q Diff
-0.16
EPS Last/This Y
-1.37
EPS This/Next Y
-0.59
Price
26.01
Target Price
89.88
Analyst Recom
1.24
Performance Q
-6.24
Relative Volume
2
Beta
0.75
Ticker: VKTX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | VKTX | 34.42 | 0.29 | 0.37 | 245649 |
| 2025-07-28 | VKTX | 33.19 | 0.29 | 0.30 | 227105 |
| 2025-07-29 | VKTX | 32.89 | 0.29 | 0.26 | 234906 |
| 2025-07-30 | VKTX | 33.7 | 0.29 | 0.25 | 237193 |
| 2025-07-31 | VKTX | 32.58 | 0.29 | 0.18 | 240928 |
| 2025-08-01 | VKTX | 32.67 | 0.28 | 0.36 | 245296 |
| 2025-08-04 | VKTX | 34 | 0.27 | 0.24 | 235200 |
| 2025-08-05 | VKTX | 34.02 | 0.27 | 0.22 | 245461 |
| 2025-08-06 | VKTX | 31.89 | 0.27 | 0.27 | 249584 |
| 2025-08-07 | VKTX | 35.54 | 0.27 | 0.16 | 258260 |
| 2025-08-08 | VKTX | 37.88 | 0.26 | 0.16 | 268607 |
| 2025-08-11 | VKTX | 38.21 | 0.27 | 0.28 | 264667 |
| 2025-08-12 | VKTX | 39.88 | 0.27 | 0.26 | 284131 |
| 2025-08-13 | VKTX | 41.18 | 0.27 | 0.20 | 291618 |
| 2025-08-14 | VKTX | 40.24 | 0.28 | 0.30 | 298918 |
| 2025-08-15 | VKTX | 40.03 | 0.30 | 0.19 | 305371 |
| 2025-08-18 | VKTX | 42.13 | 0.23 | 0.43 | 232622 |
| 2025-08-19 | VKTX | 24.33 | 0.26 | 0.36 | 256618 |
| 2025-08-20 | VKTX | 25.73 | 0.31 | 0.30 | 306830 |
| 2025-08-21 | VKTX | 25.66 | 0.30 | 0.26 | 317153 |
| 2025-08-22 | VKTX | 26.03 | 0.29 | 0.23 | 320370 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | VKTX | 34.42 | -120.3 | -27.1 | -1.84 |
| 2025-07-28 | VKTX | 33.26 | -211.8 | -87.0 | -2.40 |
| 2025-07-29 | VKTX | 32.91 | -211.8 | -96.9 | -2.40 |
| 2025-07-30 | VKTX | 33.71 | -209.3 | -110.1 | -2.39 |
| 2025-07-31 | VKTX | 32.57 | -209.3 | -86.9 | -2.39 |
| 2025-08-01 | VKTX | 32.68 | -209.3 | -101.8 | -2.39 |
| 2025-08-04 | VKTX | 33.98 | -209.3 | -116.3 | -2.39 |
| 2025-08-05 | VKTX | 34.03 | -209.3 | -101.0 | -2.39 |
| 2025-08-06 | VKTX | 31.89 | -209.3 | -75.4 | -2.39 |
| 2025-08-07 | VKTX | 35.56 | -209.3 | -147.0 | -2.39 |
| 2025-08-08 | VKTX | 37.89 | -209.3 | -126.1 | -2.39 |
| 2025-08-11 | VKTX | 38.21 | -209.3 | -103.7 | -2.39 |
| 2025-08-12 | VKTX | 39.86 | -209.3 | -117.3 | -2.37 |
| 2025-08-13 | VKTX | 41.27 | -211.8 | -113.9 | -2.37 |
| 2025-08-14 | VKTX | 40.27 | -211.8 | -91.2 | -2.38 |
| 2025-08-15 | VKTX | 40.03 | -211.8 | -98.4 | -2.38 |
| 2025-08-18 | VKTX | 42.15 | -211.8 | -120.6 | -2.38 |
| 2025-08-19 | VKTX | 24.36 | -211.8 | 58.7 | -2.38 |
| 2025-08-20 | VKTX | 25.68 | -211.8 | -124.6 | -2.38 |
| 2025-08-21 | VKTX | 25.65 | -211.8 | -99.7 | -2.38 |
| 2025-08-22 | VKTX | 26.01 | -211.8 | -106.4 | -2.38 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | VKTX | -1.01 | -5.10 | 26.25 |
| 2025-07-28 | VKTX | -1.01 | -4.88 | 26.22 |
| 2025-07-29 | VKTX | -1.01 | -4.88 | 26.22 |
| 2025-07-30 | VKTX | -1.01 | -4.88 | 26.22 |
| 2025-07-31 | VKTX | -1.01 | -4.88 | 26.22 |
| 2025-08-01 | VKTX | -1.01 | -4.88 | 26.22 |
| 2025-08-04 | VKTX | -1.01 | -4.98 | 26.22 |
| 2025-08-05 | VKTX | -1.01 | -4.98 | 26.22 |
| 2025-08-06 | VKTX | -1.01 | -4.98 | 26.22 |
| 2025-08-07 | VKTX | -1.01 | -4.98 | 26.22 |
| 2025-08-08 | VKTX | -1.01 | -4.98 | 26.22 |
| 2025-08-11 | VKTX | -1.01 | -5.04 | 26.22 |
| 2025-08-12 | VKTX | -1.01 | -5.04 | 26.31 |
| 2025-08-13 | VKTX | -1.01 | -5.04 | 26.31 |
| 2025-08-14 | VKTX | -1.01 | -5.04 | 26.31 |
| 2025-08-15 | VKTX | -1.01 | -5.04 | 26.31 |
| 2025-08-18 | VKTX | -1.01 | -2.27 | 26.31 |
| 2025-08-19 | VKTX | -1.01 | -2.27 | 26.31 |
| 2025-08-20 | VKTX | -1.01 | -2.27 | 26.31 |
| 2025-08-21 | VKTX | -1.01 | -2.27 | 26.31 |
| 2025-08-22 | VKTX | -1.01 | -2.27 | 26.31 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.58
Avg. EPS Est. Current Quarter
-0.69
Avg. EPS Est. Next Quarter
-0.74
Insider Transactions
-1.01
Institutional Transactions
-2.27
Beta
0.75
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
12
Growth Score
18
Sentiment Score
1
Actual DrawDown %
73.8
Max Drawdown 5-Year %
-78.9
Target Price
89.88
P/E
Forward P/E
PEG
P/S
P/B
3.67
P/Free Cash Flow
EPS
-1.53
Average EPS Est. Cur. Y
-2.38
EPS Next Y. (Est.)
-2.97
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
2
Return on Equity vs Sector %
-46.3
Return on Equity vs Industry %
-33.3
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.53
EBIT Estimation
-106.4
Viking Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 48
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
stock quote shares VKTX – Viking Therapeutics, Inc. Stock Price stock today
news today VKTX – Viking Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VKTX – Viking Therapeutics, Inc. yahoo finance google finance
stock history VKTX – Viking Therapeutics, Inc. invest stock market
stock prices VKTX premarket after hours
ticker VKTX fair value insiders trading